Cancer, Sleep Problems, and Metabolic Disturbances
The Impact on Quality of Life
Patients diagnosed with cancer frequently report experiencing sleep issues and metabolic disturbances, which significantly detract from their quality of life. Until recently, the underlying molecular mechanisms linking cancer to these problems were not well understood.
Research Findings from Ohio State University
A team of scientists from Ohio State University has made significant strides in uncovering the mechanisms that connect cancer to metabolic and sleep disturbances. Their findings, published in the journal Cell Metabolism, utilized a mouse model of breast cancer to demonstrate how cancer affects hormones, metabolism, and the nervous system, leading to various physiological issues.
The Role of Inflammation in Cancer
Understanding Inflammatory Responses
As cancer develops, it triggers a robust inflammatory response within the body. Previous research has established that cancer-induced inflammation can lead to metabolic complications and sleep disruptions. In this study, the authors examined various genes and cells commonly associated with inflammation across different organs in mice.
Methodology of the Study
To conduct their research, the scientists injected cancer cells into mice and subsequently collected samples from the organs of these tumor-bearing animals. They aimed to evaluate how inflammation impacts the sleep-wake cycle, focusing on gene alterations during different times of the day and night in the brain and liver of the affected mice. Given that inflammation is known to disrupt liver metabolism, they also assessed changes in liver metabolic functions throughout the day.
Influence of Sleep-Wake Cycles
Metabolic Disturbances and Timing
The study revealed that inflammation-related metabolic disturbances in the liver occurred at specific times, indicating that the sleep-wake cycles significantly influence how cancer-associated inflammation affects liver metabolism.
Effects on Nervous System Function
The researchers also explored how cancer-associated inflammation may impact various aspects of the nervous system. They discovered that certain classes of nerve cells, specifically HO (hypocretin-producing) and MCH (melanin-concentrating hormone) neurons, were affected by tumors. These neurons are known to play a role in regulating sleep patterns in mice.
Mechanisms of Sleep Disruption
Hormonal Changes Induced by Tumors
Physiological experiments indicated that tumors disrupt the production of hormones such as leptin and ghrelin. These hormonal changes impact the hypothalamus, the brain region where the HO and MCH neurons reside. Elevated hypocretin activity from these neurons was found to correlate with sleep disturbances.
Potential Interventions for Sleep Disruptions
One particularly intriguing finding was that inhibiting the signaling from HO neurons enabled the mice to overcome metabolic disturbances, leading to improved sleep quality compared to the control group. This suggests that targeting HO neurons could be a promising avenue for developing strategies to alleviate metabolic and sleep disruptions in cancer patients, ultimately enhancing their quality of life.
Conclusion
This research underscores the intricate relationship between cancer, inflammation, and physiological disturbances related to sleep and metabolism. Future investigations may focus on leveraging these findings to improve interventions for cancer patients facing similar challenges.
Reference
Borniger, J. C., Walker II, W. H., Surbhi, Emmer, K. M., Zhang, N., Zalenski, A. A., . . . DeVries, A. C. (2018). A Role for Hypocretin/Orexin in Metabolic and Sleep Abnormalities in a Mouse Model of Non-metastatic Breast Cancer. Cell Metab. doi:10.1016/j.cmet.2018.04.021